{"id":"carbetocin-bolus","safety":{"commonSideEffects":[{"rate":null,"effect":"Hypertension"},{"rate":null,"effect":"Tachycardia"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Flushing"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Carbetocin mimics the natural hormone oxytocin by activating oxytocin receptors on uterine smooth muscle, triggering sustained contractions that compress bleeding vessels and reduce postpartum hemorrhage. It has a longer duration of action and more selective receptor binding compared to oxytocin, making it effective at lower doses for prevention and treatment of uterine atony.","oneSentence":"Carbetocin is a synthetic oxytocin analogue that binds to oxytocin receptors to stimulate uterine contractions and promote hemostasis.","_ai_confidence":"high"},"_scrapedAt":"2026-03-27T23:43:12.719Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of postpartum hemorrhage following vaginal delivery"},{"name":"Prevention of postpartum hemorrhage following cesarean section"}]},"trialDetails":[{"nctId":"NCT07318467","phase":"NA","title":"Prophylactic Regimen of Intravenous Oxytocin, Intravenous Tranexamic Acid, and Intramuscular Ergot Derivative for Primary Prevention of Postpartum Hemorrhage in Intrapartum Cesarean Section Versus Intravenous Carbetocin Alone","status":"NOT_YET_RECRUITING","sponsor":"Cairo University","startDate":"2026-01-01","conditions":"Post Partum Hemorrhage","enrollment":80},{"nctId":"NCT06956365","phase":"NA","title":"To Compare the Effects of Oxytocin and Carbetocin on Intraoperative Hemodynamic Changes in Cesarean Section Surgeries.","status":"RECRUITING","sponsor":"Yuzuncu Yil University","startDate":"2024-05-14","conditions":"Cesarean Section","enrollment":80},{"nctId":"NCT06692621","phase":"","title":"Effects of Carbetocin and Oxytocin Used in Cesarean Sections on Postoperative Pain","status":"COMPLETED","sponsor":"Ankara City Hospital Bilkent","startDate":"2024-10-04","conditions":"PREG1","enrollment":120},{"nctId":"NCT06285409","phase":"NA","title":"Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium","status":"RECRUITING","sponsor":"Samuel Lunenfeld Research Institute, Mount Sinai Hospital","startDate":"2024-04-04","conditions":"Postpartum Hemorrhage","enrollment":32},{"nctId":"NCT06060327","phase":"NA","title":"Comparing Tranexamic Acid Versus Ecbolics in Preventing Hemorrhage During and After Cesarean Section","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-10-15","conditions":"Postpartum Hemorrhage, Blood Loss, Postoperative, Cesarean Section Complications","enrollment":440},{"nctId":"NCT06217354","phase":"PHASE1, PHASE2","title":"Efficacy of Carbetocin in Prevention of Postpartum Hemorrhage in Obese Versus Non Obese Women","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-07-06","conditions":"Obesity, Maternal, Post Partum Hemorrhage","enrollment":150},{"nctId":"NCT06159959","phase":"","title":"Carbetocin in the Prevention of Primary Postpartum Haemorrhage","status":"COMPLETED","sponsor":"Ministry of Health and Population, Egypt","startDate":"2023-01-01","conditions":"Post Partum Hemorrhage","enrollment":244},{"nctId":"NCT05110482","phase":"PHASE4","title":"Carbetocin Versus Syntocinon for Prevention of Postpartum Hemorrhage in Cardiac Patients Undergoing Caesarean Section","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2021-11-30","conditions":"Adverse Effect of Oxytocic Drugs","enrollment":38},{"nctId":"NCT03651882","phase":"PHASE4","title":"Oxytocin i.m./i.v. Versus Carbetocin i.v. in Elective Cesarean Sections","status":"COMPLETED","sponsor":"University of Zurich","startDate":"2018-08-07","conditions":"Postpartum Hemorrhage","enrollment":550},{"nctId":"NCT03404544","phase":"PHASE4","title":"Impact of Carbetocin Administration on Heart Rate When Given as an Infusion Versus as a Bolus.","status":"COMPLETED","sponsor":"Ciusss de L'Est de l'Île de Montréal","startDate":"2018-06-11","conditions":"Cesarean Section Complications, Hemodynamic Instability","enrollment":70},{"nctId":"NCT03716076","phase":"PHASE4","title":"Carbetocin on Myocardial Repolarization Dynamics in Obstetrics Study","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2018-11-01","conditions":"Cardiac Arrythmias","enrollment":50},{"nctId":"NCT04357015","phase":"PHASE4","title":"Intravenous Tranexamic Acid Versus IV Carbetocin in Abdominal Myomectomy","status":"UNKNOWN","sponsor":"Cairo University","startDate":"2020-05-01","conditions":"Myomectomy","enrollment":153},{"nctId":"NCT04300452","phase":"PHASE4","title":"Carbetocin Versus Ergometrin in the Prevention of Postpartum Hemorrhage","status":"UNKNOWN","sponsor":"National and Kapodistrian University of Athens","startDate":"2018-04-05","conditions":"Postpartum Hemorrhage","enrollment":100},{"nctId":"NCT03755531","phase":"PHASE4","title":"Carbetocin Versus Oxytocin for the Prevention of Postpartum Hemorrhage in Emergency Caesarean Delivery","status":"COMPLETED","sponsor":"Al-Kindy College of Medicine","startDate":"2018-01-04","conditions":"Postpartum Hemorrhage (Primary)","enrollment":300},{"nctId":"NCT02221531","phase":"PHASE4","title":"Carbetocin Trial: Carbetocin Appropriate Rate Better Equilibrium Between Tonus (TOnus) and CIrculatioN","status":"COMPLETED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2014-08","conditions":"Complications; Cesarean Section, Anesthesia; Reaction","enrollment":140},{"nctId":"NCT02636816","phase":"PHASE4","title":"Cardiovascular Effects of Carbetocin Given During Elective Cesarean","status":"COMPLETED","sponsor":"University of British Columbia","startDate":"2016-03","conditions":"Effect of Carbetocin on Cardiovascular System, Pregnancy","enrollment":57},{"nctId":"NCT01719952","phase":"NA","title":"Haemodynamic and Cardiovascular Effects of Carbetocin and Oxytocin","status":"COMPLETED","sponsor":"Universiti Kebangsaan Malaysia Medical Centre","startDate":"2012-01","conditions":"Pregnancy Related, Anaesthesia","enrollment":50}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Duratocin"],"phase":"marketed","status":"active","brandName":"Carbetocin bolus","genericName":"Carbetocin bolus","companyName":"Ciusss de L'Est de l'Île de Montréal","companyId":"ciusss-de-l-est-de-l-le-de-montr-al","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Carbetocin is a synthetic oxytocin analogue that binds to oxytocin receptors to stimulate uterine contractions and promote hemostasis. Used for Prevention of postpartum hemorrhage following vaginal delivery, Prevention of postpartum hemorrhage following cesarean section.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}